Search Results

Displaying Results 7676-7700 of 28369 "'B'"

Jun 30, 2026, 07:37 ET SBI Life Partners with IIT Bombay to Build India's Own AI-Powered Cyber Defence systems for Insurance

Dean-R&D, IIT- Bombay and Mr. Vishal Bhatia, Chief Information & Digital Officer, SBI Life Insurance in presence of Prof. Shireesh B Kedare, Director, IIT-Bombay; Mr. Abhijit Gulanikar, President - Ops & IT, SBI Life; Mr. Subhendu Bal, President - Chief Risk Officer, SBI Life; Mr.

More news about: SBI Life Insurance


Jun 30, 2026, 07:32 ET GreenTree Hospitality Group Ltd. Reports First Quarter of 2026 Financial Results

32,268,349Class B ordinary shares115,534,210

More news about: GreenTree Hospitality Group Ltd.


Jun 30, 2026, 07:30 ET Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator

criteria and endpoints with a 12-week double-blind treatment period and evaluates opakalim 25 mg and 50 mg once-daily in Part A and 75 mg once-daily in Part B.In May 2026, at its R&D Day, Biohaven showcased evidence supporting the promise of opakalim to address the unmet need for a novel, effective,

More news about: Biohaven Ltd.


Jun 30, 2026, 07:15 ET ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial

compendia pathways for the combination.About LOTIS-7LOTIS-7 is a Phase 1b global multicenter, multi-arm study in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) including Part 1 (dose escalation) and Part 2 (dose expansion). The three dosing arms include

More news about: ADC Therapeutics SA


Jun 30, 2026, 07:06 ET 카르파워십, 새로운 300MW '씨라이언' 클래스 파워십으로 글로벌 선단 확장

content:https://www.prnewswire.com/kr/news-releases/uCE74uB974uD30CuC6CCuC2EDu002Cu002DuC0C8uB85CuC6B4u002Du0033u0030u0030u006Du0077u002Du0027uC528uB77CuC774uC5B8u0027u002DuD074uB798uC2A4u002D-302814441.htmlSOURCE

More news about: Karpowership


Jun 30, 2026, 07:05 ET Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

Score (TMS), Symbol Digit Modalities Test (SDMT), and Stroop Word Reading Test (SWRT).The Phase 1/2 trial consists of three parts. Parts A and B evaluated SKY-0515 in Healthy Volunteers. Part C is a randomized, double-blind, placebo-controlled parallel-group study evaluating two dose levels of

More news about: Skyhawk Therapeutics


Jun 30, 2026, 07:00 ET Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances

traded clinical-stage entity, raising more than $1.2B and expanding to 180 employees across the US and Europe. Under his leadership, the company also advanced multiple development programs and established significant strategic partnerships, including a $2B collaboration with GSK.    "Rita and the

More news about: Muna Therapeutics


Jun 30, 2026, 07:00 ET Lufax Announces Results of Annual General Meeting

2025 and the reports of the Directors and Auditors thereon.(a) To re-elect Mr. Xiang JI as an executive Director;(b) To re-elect Mr. Tongzhuan XI as an executive Director;(c) To re-elect Ms. Fangfang CAI as a non-executive Director;(d) To re-elect

More news about: Lufax Holding Ltd


Jun 30, 2026, 07:00 ET Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

Score (TMS), Symbol Digit Modalities Test (SDMT), and Stroop Word Reading Test (SWRT).The Phase 1/2 trial consists of three parts. Parts A and B evaluated SKY-0515 in Healthy Volunteers. Part C is a randomized, double-blind, placebo-controlled parallel-group study evaluating two dose levels of

More news about: Skyhawk Therapeutics


Jun 30, 2026, 06:59 ET Autonomous Trucks Market worth $158.69 billion by 2035 | MarketsandMarkets™

alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80%

More news about: MarketsandMarkets


Jun 30, 2026, 06:50 ET ATRenew Releases 2025 ESG Report: Advancing Sustainable Growth by Leading the Circular Economy

pre-owned consumer products by facilitating recycling, trade-ins and distribution that prolong their lifecycle. ATRenew's open platform integrates C2B, B2B, and B2C capabilities to empower its online and offline services. Powered by proprietary technologies and a scalable platform ecosystem, ATRenew enhances

More news about: ATRenew Inc.


Jun 30, 2026, 06:40 ET Data Center Liquid Cooling Manifolds Market worth $6.33 billion by 2033 - Exclusive Report by MarketsandMarkets™

alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80%

More news about: MarketsandMarkets


Jun 30, 2026, 06:30 ET Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.

completion of this report provides the foundation for our next regulatory interactions and advances our preparations for additional dosing studies and Phase 1b/2a clinical development."CYT-108 is a recombinant variant of Alpha-2-Macroglobulin (A2M), a naturally occurring broad-spectrum protease inhibitor.

More news about: Cytonics Corporation


Jun 30, 2026, 06:30 ET Eminent Reports Airborne Geophysical Survey Results at Hot Springs Range

Qualified PersonThe scientific and technical information contained in this news release has been reviewed and approved by Justin B. Milliard, P.Geo., Vice President of Exploration for the Company and a non‑independent Qualified Person as defined in National Instrument 43‑101 – Standards

More news about: Eminent Gold Corp.


Jun 30, 2026, 06:26 ET 넷이즈 클라우드 뮤직(NetEase Cloud Music), K-POP 중국 시장 진출의 핵심 플랫폼으로 부상…

content:https://www.prnewswire.com/kr/news-releases/uB137uC774uC988u002DuD074uB77CuC6B0uB4DCu002DuBBA4uC9C1u0028u006Eu0065u0074u0065u0061u0073u0065u002Du0063u006Cu006Fu0075u0064u002Du006Du0075-302814384.htmlSOURCE

More news about: NetEase Cloud Music


Jun 30, 2026, 06:24 ET $MSFT Notification: Microsoft Accused of Misrepresentations about its Copilot Issues in Securities Fraud Class Action

until August 11, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Microsoft common stock. The class action is pending in the U.S. District

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:23 ET $GRAL Notification: GRAIL, Inc. Accused of Misrepresentations about its Trial Results in Securities Fraud Class Action

have until August 4, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in GRAIL common stock. The class action is pending in the U.S. District Court

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:17 ET $EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action

until August 17, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Embecta common stock. The class action is pending in the U.S. District Court

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:16 ET $BTU Notification: Peabody Accused of Misrepresentations about its Centurion Production Issues in Securities Fraud Class Action

until August 24, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Peabody common stock. The class action is pending in the U.S. District Court

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:16 ET $Z, $ZG Notification: Zillow Accused of Misrepresentations about its Anticompetitive Agreement in Securities Fraud Class Action

until August 10, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Zillow Class C and Class A common stock. The class action is pending in the

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:16 ET $AVAV Notification: AeroVironment Accused of Misrepresentations about its SCAR Contract Cancellation in Securities Fraud Class Action

have until July 27, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in AeroVironment securities. The class action is pending in the U.S. District

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:14 ET $ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action

until August 10, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ADMA securities. The class action is pending in the U.S. District Court for

More news about: Bleichmar Fonti & Auld LLP


Jun 30, 2026, 06:07 ET Loftware and BearingPoint Partner to Enable Connected, Scalable Supply Chain Transformation

sustainable impact.BearingPoint is recognized among TIME World's Best Companies and Forbes World's Best Employers. The firm is also a certified B Corporation, committed to responsible business and creating long-term value for organizations, people, and society.For more information, please

More news about: Loftware, Inc.


Jun 30, 2026, 06:00 ET Feathery Tops $2B in Quarterly Transition Volume, Accelerating AI-Powered Advisor Transitions

content:https://www.prnewswire.com/news-releases/feathery-tops-2b-in-quarterly-transition-volume-accelerating-ai-powered-advisor-transitions-302814043.htmlSOURCE

More news about: Feathery


Jun 30, 2026, 06:00 ET Winners Announced for 2026 International Braille Challenge Finals

Charity B. – Louisiana Freshman: Elizabeth C. - Minnesota Sophomore: Luke F. – North Carolina Junior Varsity: Salome C. - Missouri Varsity: EmmaGrace O. - TexasSECOND PLACE Apprentice: Awnaleesa S. - Colorado Freshman: Bijou B. - Florida

More news about: Braille Institute of America


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.